News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
RIGBY JONATHAN
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/01/2019 |
4
| RIGBY JONATHAN (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns:
| Granted 20,000 options to buy
@ $10, valued at
$200k
|
|
09/04/2018 |
4
| RIGBY JONATHAN (President and CEO) has filed a Form 4 on SteadyMed Ltd.
Txns:
| Sold 41,605 shares
@ $4.46, valued at
$185.6k
Sold 4,960 shares
@ $4.46, valued at
$22.1k
Disposed of 18,515 options to buy
@ $3.61, valued at
$66.8k
Disposed of 145,212 options to buy
@ $3.61, valued at
$524.2k
Disposed of 131,451 options to buy
@ $5.84, valued at
$767.7k
Disposed of 63,764 options to buy
@ $2.74, valued at
$174.7k
Disposed of 163,394 options to buy
@ $3.65, valued at
$596.4k
|
|
08/27/2018 |
4
| RIGBY JONATHAN (President and CEO) has filed a Form 4 on SteadyMed Ltd.
Txns:
| Sold 44,242 shares
@ $4.7289, valued at
$209.2k
Sold 16,994 shares
@ $4.7, valued at
$79.9k
Exercised 44,242 options to buy
@ $2.74, valued at
$121.2k
Exercised 16,994 options to buy
@ $2.74, valued at
$46.6k
|
|
08/17/2018 |
4
| RIGBY JONATHAN (President and CEO) has filed a Form 4 on SteadyMed Ltd.
Txns:
| Sold 88,831 shares
@ $4.6576, valued at
$413.7k
|
|
08/10/2018 |
4
| RIGBY JONATHAN (President and CEO) has filed a Form 4 on SteadyMed Ltd.
Txns:
| Exercised 88,831 options to buy
@ $3.61, valued at
$320.7k
|
|
07/03/2018 |
4
| RIGBY JONATHAN (President and CEO) has filed a Form 4 on SteadyMed Ltd.
Txns:
| Sold 41,605 shares
@ $4.5, valued at
$187.2k
Sold 4,961 shares
@ $4.5, valued at
$22.3k
|
|
06/20/2018 |
3
| RIGBY JONATHAN (Director) has filed a Form 3 on XERIS PHARMACEUTICALS INC |
12/28/2017 |
4
| RIGBY JONATHAN (President and CEO) has filed a Form 4 on SteadyMed Ltd.
Txns:
| Granted 83,210 shares
@ $0 Granted 163,394 options to buy
@ $3.65, valued at
$596.4k
|
|
07/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|